The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
<h4>Objectives</h4>To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV.<h4>Design</h4>This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial,...
Guardado en:
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | article |
| Lenguaje: | EN |
| Publicado: |
Public Library of Science (PLoS)
2013
|
| Materias: | |
| Acceso en línea: | https://doaj.org/article/f86cde4d9ae04cb7a90ab80fcd325343 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| id |
oai:doaj.org-article:f86cde4d9ae04cb7a90ab80fcd325343 |
|---|---|
| record_format |
dspace |
| spelling |
oai:doaj.org-article:f86cde4d9ae04cb7a90ab80fcd3253432021-11-18T08:49:52ZThe immunological and virological consequences of planned treatment interruptions in children with HIV infection.1932-620310.1371/journal.pone.0076582https://doaj.org/article/f86cde4d9ae04cb7a90ab80fcd3253432013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24194841/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Objectives</h4>To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV.<h4>Design</h4>This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial, which compared CD4-guided PTI of antiretroviral therapy (ART) with continuous therapy (CT) in children.<h4>Methods</h4>HIV-1 RNA and lymphocyte subsets, including CD4 and CD8 cells, were quantified on fresh samples collected during the study; CD45RA, CD45RO and CD31 subpopulations were evaluated in some centres. For 36 (18 PTI, 18 CT) children, immunophenotyping was performed and cell-associated HIV-1 DNA analysed on stored samples to 48 weeks.<h4>Results</h4>In the PTI group, CD4 cell count fell rapidly in the first 12 weeks off ART, with decreases in both naïve and memory cells. However, the proportion of CD4 cells expressing CD45RA and CD45RO remained constant in both groups. The increase in CD8 cells in the first 12 weeks off ART in the PTI group was predominantly due to increases in RO-expressing cells. PTI was associated with a rapid and sustained increase in CD4 cells expressing Ki67 and HLA-DR, and increased levels of HIV-1 DNA.<h4>Conclusions</h4>PTI in children is associated with rapid changes in CD4 and CD8 cells, likely due to increased cell turnover and immune activation. However, children off treatment may be able to maintain stable levels of naïve CD4 cells, at least in proportion to the memory cell pool, which may in part explain the observed excellent CD4 cell recovery with re-introduction of ART.Nigel KleinDelali SefeIlaria MosconiMarisa ZanchettaHannah CastroMarianne JacobsenHannah JonesStefania BernardiDeenan PillayCarlo GiaquintoA Sarah WalkerDiana M GibbAnita De RossiPaediatric European Network for Treatment of AIDS 11 Trial TeamPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 10, p e76582 (2013) |
| institution |
DOAJ |
| collection |
DOAJ |
| language |
EN |
| topic |
Medicine R Science Q |
| spellingShingle |
Medicine R Science Q Nigel Klein Delali Sefe Ilaria Mosconi Marisa Zanchetta Hannah Castro Marianne Jacobsen Hannah Jones Stefania Bernardi Deenan Pillay Carlo Giaquinto A Sarah Walker Diana M Gibb Anita De Rossi Paediatric European Network for Treatment of AIDS 11 Trial Team The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| description |
<h4>Objectives</h4>To evaluate the immunological and viral consequences of planned treatment interruptions (PTI) in children with HIV.<h4>Design</h4>This was an immunological and virological sub-study of the Paediatric European Network for Treatment of AIDS (PENTA) 11 trial, which compared CD4-guided PTI of antiretroviral therapy (ART) with continuous therapy (CT) in children.<h4>Methods</h4>HIV-1 RNA and lymphocyte subsets, including CD4 and CD8 cells, were quantified on fresh samples collected during the study; CD45RA, CD45RO and CD31 subpopulations were evaluated in some centres. For 36 (18 PTI, 18 CT) children, immunophenotyping was performed and cell-associated HIV-1 DNA analysed on stored samples to 48 weeks.<h4>Results</h4>In the PTI group, CD4 cell count fell rapidly in the first 12 weeks off ART, with decreases in both naïve and memory cells. However, the proportion of CD4 cells expressing CD45RA and CD45RO remained constant in both groups. The increase in CD8 cells in the first 12 weeks off ART in the PTI group was predominantly due to increases in RO-expressing cells. PTI was associated with a rapid and sustained increase in CD4 cells expressing Ki67 and HLA-DR, and increased levels of HIV-1 DNA.<h4>Conclusions</h4>PTI in children is associated with rapid changes in CD4 and CD8 cells, likely due to increased cell turnover and immune activation. However, children off treatment may be able to maintain stable levels of naïve CD4 cells, at least in proportion to the memory cell pool, which may in part explain the observed excellent CD4 cell recovery with re-introduction of ART. |
| format |
article |
| author |
Nigel Klein Delali Sefe Ilaria Mosconi Marisa Zanchetta Hannah Castro Marianne Jacobsen Hannah Jones Stefania Bernardi Deenan Pillay Carlo Giaquinto A Sarah Walker Diana M Gibb Anita De Rossi Paediatric European Network for Treatment of AIDS 11 Trial Team |
| author_facet |
Nigel Klein Delali Sefe Ilaria Mosconi Marisa Zanchetta Hannah Castro Marianne Jacobsen Hannah Jones Stefania Bernardi Deenan Pillay Carlo Giaquinto A Sarah Walker Diana M Gibb Anita De Rossi Paediatric European Network for Treatment of AIDS 11 Trial Team |
| author_sort |
Nigel Klein |
| title |
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| title_short |
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| title_full |
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| title_fullStr |
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| title_full_unstemmed |
The immunological and virological consequences of planned treatment interruptions in children with HIV infection. |
| title_sort |
immunological and virological consequences of planned treatment interruptions in children with hiv infection. |
| publisher |
Public Library of Science (PLoS) |
| publishDate |
2013 |
| url |
https://doaj.org/article/f86cde4d9ae04cb7a90ab80fcd325343 |
| work_keys_str_mv |
AT nigelklein theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT delalisefe theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT ilariamosconi theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT marisazanchetta theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT hannahcastro theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT mariannejacobsen theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT hannahjones theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT stefaniabernardi theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT deenanpillay theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT carlogiaquinto theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT asarahwalker theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT dianamgibb theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT anitaderossi theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT paediatriceuropeannetworkfortreatmentofaids11trialteam theimmunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT nigelklein immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT delalisefe immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT ilariamosconi immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT marisazanchetta immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT hannahcastro immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT mariannejacobsen immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT hannahjones immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT stefaniabernardi immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT deenanpillay immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT carlogiaquinto immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT asarahwalker immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT dianamgibb immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT anitaderossi immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection AT paediatriceuropeannetworkfortreatmentofaids11trialteam immunologicalandvirologicalconsequencesofplannedtreatmentinterruptionsinchildrenwithhivinfection |
| _version_ |
1718421300321452032 |